Given the well-known role for MLL in leukemias, and the increasing focus on abnormal epigenetic regulation in cancer, the results of this study present a strong argument for further investigation of MLL2 and its possible involvement in solid tumors. The gene discussed is KMT2A; the disease is cancer.